Clinical trial highlights efficacy of imlifidase for kidney transplant recipients

For kidney transplant recipients experiencing antibody-mediated rejection, the current standard of care involves removing donor-specific antibodies (DSAs) through plasmapheresis (PLEX)-;a procedure that removes antibodies from the plasma portion of the blood.

Pediatrix Deploys AI-Powered Prenatal Care with Sonio

What You Should Know: – Pediatrix Medical Group, a provider of specialized healthcare for women, children, and babies in the U.S., is making waves by

January 31, 2024

Bispecific antibody startup Bambusa raises $90m to fund clinical trials – Pharmaceutical Technology

Bambusa’s lead candidate BBT001 is being investigated for dermatologic indications. Credit: kirisa99 via Getty Images. US-based startup Bambusa Therapeutics has secured $90m in Series A

February 17, 2025

Precise protein design offers hope for damaged hearts and kidneys

Using computer-designed proteins, researchers have now shown they are able to direct human stem cells to form new blood vessels in the lab. This milestone

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.